Zobrazeno 1 - 10
of 248
pro vyhledávání: '"Emeline M, Van Craenenbroeck"'
Autor:
Dustin N. Krüger, Matthias Bosman, Emeline M. Van Craenenbroeck, Guido R. Y. De Meyer, Constantijn Franssen, Pieter-Jan Guns
Publikováno v:
Cardio-Oncology, Vol 10, Iss 1, Pp 1-11 (2024)
Abstract Background Doxorubicin (DOX) is used for breast cancer and lymphoma, but can cause cardiotoxicity, arterial stiffness, and endothelial dysfunction. We recently reported SERPINA3N as biomarker of cardiovascular toxicity in patients and mice.
Externí odkaz:
https://doaj.org/article/56a98f05017b45b4b30d87d48e86a2eb
Autor:
Dustin N. Krüger, Matthias Bosman, Charles X.L. Van Assche, Callan D. Wesley, Berta Cillero-Pastor, Leen Delrue, Ward Heggermont, Jozef Bartunek, Guido R. Y. De Meyer, Emeline M. Van Craenenbroeck, Pieter-Jan Guns, Constantijn Franssen
Publikováno v:
Cardio-Oncology, Vol 10, Iss 1, Pp 1-17 (2024)
Abstract Background The anthracycline doxorubicin (DOX) is a highly effective anticancer agent, especially in breast cancer and lymphoma. However, DOX can cause cancer therapy-related cardiovascular toxicity (CTR-CVT) in patients during treatment and
Externí odkaz:
https://doaj.org/article/be96370b15b24456a6a68e11cd636233
Autor:
Hanne M. Boen, Maaike Alaerts, Inge Goovaerts, Johan B. Saenen, Constantijn Franssen, Anne Vorlat, Tom Vermeulen, Hein Heidbuchel, Lut Van Laer, Bart Loeys, Emeline M. Van Craenenbroeck
Publikováno v:
Cardio-Oncology, Vol 10, Iss 1, Pp 1-12 (2024)
Abstract Background Variants in cardiomyopathy genes have been identified in patients with cancer therapy-related cardiac dysfunction (CTRCD), suggesting a genetic predisposition for the development of CTRCD. The diagnostic yield of genetic testing i
Externí odkaz:
https://doaj.org/article/d722bd93cc5b4cb3bf0e63ce250ce1f0
Autor:
Egil Riveland, Torstein Valborgland, Anastasia Ushakova, Øyvind Skadberg, Trine Karlsen, Torstein Hole, Asbjørn Støylen, Håvard Dalen, Vibeke Videm, Elias Koppen, Axel Linke, Charles Delagardelle, Emeline M. Van Craenenbroeck, Paul Beckers, Eva Prescott, Martin Halle, Torbjørn Omland, Øyvind Ellingsen, Alf Inge Larsen, the SMARTEX‐HF Study Group
Publikováno v:
ESC Heart Failure, Vol 11, Iss 2, Pp 1121-1132 (2024)
Abstract Aims The aims of this sub‐study of the SMARTEX trial were (1) to evaluate the effects of a 12‐week exercise training programme on serum levels of high sensitivity cardiac troponin I (hs‐cTnI) in patients with moderate chronic heart fai
Externí odkaz:
https://doaj.org/article/603ef4ac139d44c8af268206d2c120ff
Autor:
Hanne M. Boen, Bert Vandendriessche, Jolien Schippers, Laura Rabaut, Aleksandra Nijak-Paeske, Peter Ponsaerts, Emeline M. Van Craenenbroeck, Bart Loeys, Maaike Alaerts
Publikováno v:
Stem Cell Research, Vol 81, Iss , Pp 103536- (2024)
Truncating variants in TTN (TTNtv) are present in 15–25 % of patients with idiopathic dilated cardiomyopathy. Interestingly, the pathogenicity of TTNtv seems to be linked to their location within the gene. More proximal I-band TTNtv (TTNtvI) harbou
Externí odkaz:
https://doaj.org/article/c3299bc2be0e424f95b05a7926882f59
Autor:
Maria Simonenko, Dominique Hansen, Josef Niebauer, Maurizio Volterrani, Stamatis Adamopoulos, Cristiano Amarelli, Marco Ambrosetti, Stefan D. Anker, Antonio Bayes-Genis, Tuvia Ben Gal, T. Scott Bowen, Francesco Cacciatore, Giuseppe Caminiti, Elena Cavarretta, Ovidiu Chioncel, Andrew J. S. Coats, Alain Cohen-Solal, Flavio D’Ascenzi, Carmen de Pablo Zarzosa, Andreas B. Gevaert, Finn Gustafsson, Hareld Kemps, Loreena Hill, Tiny Jaarsma, Ewa Jankowska, Emer Joyce, Nicolle Krankel, Mitja Lainscak, Lars H. Lund, Brenda Moura, Kari Nytrøen, Elena Osto, Massimo Piepoli, Luciano Potena, Amina Rakisheva, Giuseppe Rosano, Gianluigi Savarese, Petar M. Seferovic, David R. Thompson, Thomas Thum, Emeline M. Van Craenenbroeck
Publikováno v:
Transplant International, Vol 37 (2024)
Little is known either about either physical activity patterns, or other lifestyle-related prevention measures in heart transplantation (HTx) recipients. The history of HTx started more than 50 years ago but there are still no guidelines or position
Externí odkaz:
https://doaj.org/article/4ccdc9317262421e9229c4fb891db94d
Autor:
Hanne M. Boen, Maaike Alaerts, Lut Van Laer, Johan B. Saenen, Inge Goovaerts, Jarl Bastianen, Pieter Koopman, Philippe Vanduynhoven, Elke De Vuyst, Michael Rosseel, Hein Heidbuchel, Emeline M. Van Craenenbroeck, Bart Loeys
Publikováno v:
Frontiers in Genetics, Vol 15 (2024)
BackgroundVariants in the MYBPC3 gene are a frequent cause of hypertrophic cardiomyopathy (HCM) but display a large phenotypic heterogeneity. Founder mutations are often believed to be more benign as they prevailed despite potential negative selectio
Externí odkaz:
https://doaj.org/article/ff57bde99f3543aea920e69875af395f
Autor:
Jente R. A. Boen, Andreas B. Gevaert, Amélie Dendooven, Dustin Krüger, Michiel Tubeeckx, Jens Van Fraeyenhove, Tine Bruyns, Vincent F. M. Segers, Emeline M. Van Craenenbroeck
Publikováno v:
Frontiers in Cardiovascular Medicine, Vol 11 (2024)
AimsMiR-181c-5p overexpression associates with heart failure (HF) and cardiac damage, but the underlying pathophysiology remains unclear. This study investigated the effect of miR-181c-5p inhibition on cardiac function and fibrosis in a rodent model
Externí odkaz:
https://doaj.org/article/cae434e6b83d432aa3c619f3a34d5a6b
Autor:
Katharina Lechner, Sylvia Kia, Pia von Korn, Sophia M. Dinges, Stephan Mueller, Arnt-Erik Tjønna, Ulrik Wisløff, Emeline M. Van Craenenbroeck, Burkert Pieske, Volker Adams, Axel Pressler, Ulf Landmesser, Martin Halle, Nicolle Kränkel
Publikováno v:
Frontiers in Cardiovascular Medicine, Vol 11 (2024)
BackgroundMetabolic syndrome (MetS) is defined by the presence of central obesity plus ≥two metabolic/cardiovascular risk factors (RF), with inflammation being a major disease-driving mechanism. Structured endurance exercise training (ET) may posit
Externí odkaz:
https://doaj.org/article/c38112165f794ac9b20e315531e45ac9
Autor:
Sumant P. Radhoe, Jesse F. Veenis, Nina Jakus, Philippe Timmermans, Anne‐Catherine Pouleur, Pawel Rubís, Emeline M. Van Craenenbroeck, Edvinas Gaizauskas, Eduardo Barge‐Caballero, Stefania Paolillo, Sebastian Grundmann, Domenico D'Amario, Oscar Ö. Braun, Aggeliki Gkouziouta, Ivo Planinc, Jure Samardzic, Bart Meyns, Walter Droogne, Karol Wierzbicki, Katarzyna Holcman, Andreas J. Flammer, Hrvoje Gasparovic, Bojan Biocina, Lars H. Lund, Davor Milicic, Frank Ruschitzka, Maja Cikes, Jasper J. Brugts
Publikováno v:
ESC Heart Failure, Vol 10, Iss 2, Pp 884-894 (2023)
Abstract Aims Use of left ventricular assist devices (LVADs) in older patients has increased, and assessing outcomes in older LVAD recipients is important. Therefore, this study aimed to investigate associations between age and outcomes after continu
Externí odkaz:
https://doaj.org/article/61ec7b7f053445acb6d5c3ce84fbc5d3